385 related articles for article (PubMed ID: 23760857)
1. Differential characteristics of heart, liver, and brain metastatic subsets of murine breast carcinoma.
Erin N; Kale S; Tanrıöver G; Köksoy S; Duymuş O; Korcum AF
Breast Cancer Res Treat; 2013 Jun; 139(3):677-89. PubMed ID: 23760857
[TBL] [Abstract][Full Text] [Related]
2. Autocrine control of MIP-2 secretion from metastatic breast cancer cells is mediated by CXCR2: a mechanism for possible resistance to CXCR2 antagonists.
Erin N; Nizam E; Tanrıöver G; Köksoy S
Breast Cancer Res Treat; 2015 Feb; 150(1):57-69. PubMed ID: 25682075
[TBL] [Abstract][Full Text] [Related]
3. Altered gene expression in breast cancer liver metastases.
Erin N; Wang N; Xin P; Bui V; Weisz J; Barkan GA; Zhao W; Shearer D; Clawson GA
Int J Cancer; 2009 Apr; 124(7):1503-16. PubMed ID: 19117052
[TBL] [Abstract][Full Text] [Related]
4. Metastatic breast carcinoma induces vascular endothelial dysfunction in Balb-c mice: Role of the tumor necrosis factor-α and NADPH oxidase.
Dalaklioglu S; Tasatargil A; Kale S; Tanriover G; Dilmac S; Erin N
Vascul Pharmacol; 2013; 59(3-4):103-11. PubMed ID: 23933568
[TBL] [Abstract][Full Text] [Related]
5. Nephronectin is Decreased in Metastatic Breast Carcinoma and Related to Metastatic Organs.
Dilmac S; Erin N; Demir N; Tanriover G
Pathol Oncol Res; 2018 Jul; 24(3):679-688. PubMed ID: 28842827
[TBL] [Abstract][Full Text] [Related]
6. NK1R antagonist decreases inflammation and metastasis of breast carcinoma cells metastasized to liver but not to brain; phenotype-dependent therapeutic and toxic consequences.
Nizam E; Köksoy S; Erin N
Cancer Immunol Immunother; 2020 Aug; 69(8):1639-1650. PubMed ID: 32322911
[TBL] [Abstract][Full Text] [Related]
7. Comparison of immunity in mice cured of primary/metastatic growth of EMT6 or 4THM breast cancer by chemotherapy or immunotherapy.
Gorczynski RM; Chen Z; Erin N; Khatri I; Podnos A
PLoS One; 2014; 9(11):e113597. PubMed ID: 25409195
[TBL] [Abstract][Full Text] [Related]
8. HSP90 inhibitor PU-H71 increases radiosensitivity of breast cancer cells metastasized to visceral organs and alters the levels of inflammatory mediators.
Kale Ş; Korcum AF; Dündar E; Erin N
Naunyn Schmiedebergs Arch Pharmacol; 2020 Feb; 393(2):253-262. PubMed ID: 31522240
[TBL] [Abstract][Full Text] [Related]
9. Secretomes reveal several novel proteins as well as TGF-β1 as the top upstream regulator of metastatic process in breast cancer.
Erin N; Ogan N; Yerlikaya A
Breast Cancer Res Treat; 2018 Jul; 170(2):235-250. PubMed ID: 29557524
[TBL] [Abstract][Full Text] [Related]
10. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
11. Presence of S100A8/Gr1-Positive Myeloid-Derived Suppressor Cells in Primary Tumors and Visceral Organs Invaded by Breast Carcinoma Cells.
Tanriover G; Eyinc MB; Aliyev E; Dilmac S; Erin N
Clin Breast Cancer; 2018 Oct; 18(5):e1067-e1076. PubMed ID: 29804651
[TBL] [Abstract][Full Text] [Related]
12. CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome.
Idowu MO; Kmieciak M; Dumur C; Burton RS; Grimes MM; Powers CN; Manjili MH
Hum Pathol; 2012 Mar; 43(3):364-73. PubMed ID: 21835433
[TBL] [Abstract][Full Text] [Related]
13. Bcl-2/adenovirus E1B 19 kDa interacting protein-3 knockdown enables growth of breast cancer metastases in the lung, liver, and bone.
Manka D; Spicer Z; Millhorn DE
Cancer Res; 2005 Dec; 65(24):11689-93. PubMed ID: 16357180
[TBL] [Abstract][Full Text] [Related]
14. Differential consequences of neurokinin receptor 1 and 2 antagonists in metastatic breast carcinoma cells; Effects independent of Substance P.
Nizam E; Erin N
Biomed Pharmacother; 2018 Dec; 108():263-270. PubMed ID: 30223097
[TBL] [Abstract][Full Text] [Related]
15. A novel mouse model of human breast cancer stem-like cells with high CD44+CD24-/lower phenotype metastasis to human bone.
Ling LJ; Wang S; Liu XA; Shen EC; Ding Q; Lu C; Xu J; Cao QH; Zhu HQ; Wang F
Chin Med J (Engl); 2008 Oct; 121(20):1980-6. PubMed ID: 19080260
[TBL] [Abstract][Full Text] [Related]
16. Tranilast inhibits the growth and metastasis of mammary carcinoma.
Chakrabarti R; Subramaniam V; Abdalla S; Jothy S; Prud'homme GJ
Anticancer Drugs; 2009 Jun; 20(5):334-45. PubMed ID: 19322072
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer-associated fibroblasts induce epithelial-to-mesenchymal transition in breast cancer cells.
Soon PS; Kim E; Pon CK; Gill AJ; Moore K; Spillane AJ; Benn DE; Baxter RC
Endocr Relat Cancer; 2013 Feb; 20(1):1-12. PubMed ID: 23111755
[TBL] [Abstract][Full Text] [Related]
18. Epithelial-mesenchymal transition (EMT) is not sufficient for spontaneous murine breast cancer metastasis.
Lou Y; Preobrazhenska O; auf dem Keller U; Sutcliffe M; Barclay L; McDonald PC; Roskelley C; Overall CM; Dedhar S
Dev Dyn; 2008 Oct; 237(10):2755-68. PubMed ID: 18773493
[TBL] [Abstract][Full Text] [Related]
19. The clinicopathological significance of CD44+/CD24-/low and CD24+ tumor cells in invasive micropapillary carcinoma of the breast.
Li W; Liu F; Lei T; Xu X; Liu B; Cui L; Wei J; Guo X; Lang R; Fan Y; Gu F; Tang P; Zhang X; Fu L
Pathol Res Pract; 2010 Dec; 206(12):828-34. PubMed ID: 20977976
[TBL] [Abstract][Full Text] [Related]
20. Preferential killing of breast tumor initiating cells by N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine/tesmilifene.
Deng T; Liu JC; Pritchard KI; Eisen A; Zacksenhaus E
Clin Cancer Res; 2009 Jan; 15(1):119-30. PubMed ID: 19118039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
